The LIPT2 gene helps the energy-making parts of your cells activate several proteins by attaching a small helper molecule called lipoic acid. If this gene does not work properly, cells may struggle to make energy, especially in the brain and other high-demand tissues. Rare harmful variants in the LIPT2 gene are linked to a severe mitochondrial condition that can cause feeding problems, low muscle tone, seizures, lactic acidosis, and delayed development starting early in life. This is not a gene that has become widely known in popular culture.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or regulate activities in the body. Some genes provide the directions for producing proteins, which do much of the cell’s work. Others mainly control when certain activities happen, where they take place, and how strongly they operate. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. For a closer look at this topic, you can find more in the LearnHub.
Overview
LIPT2Gene function
What if the gene works
The LIPT2 gene helps mitochondria make lipoic acid, a small helper needed for energy enzymes. This supports how cells turn food into energy and process certain amino acids.
Risk
What if the gene does not work
More severe variants in the LIPT2 gene can cause a rare mitochondrial disease with early brain symptoms, seizures, low muscle tone, and lactic acidosis. Milder variants may cause later onset or fewer features.
Treatment
What does that mean for your treatment
No LIPT2-specific treatment or drug choice is currently established in clinical guidelines. The mitochondrial lipoic acid pathway is being studied in early research, but no targeted medicine has yet been shown to reliably help people with pathogenic variants in the LIPT2 gene.
Conditions associated with LIPT2
Gene function
What if the gene works
Your cells need a steady way to turn food into usable energy. Inside mitochondria (the parts of cells that make most energy), the LIPT2 gene helps set up lipoic acid, a small helper molecule that several enzymes need. This is part of how the LIPT2 gene supports energy production in mitochondria and routine cell activity.
Inside mitochondria, the LIPT2 gene helps attach a small fatty chain to a helper protein. This starts the steps that lead to lipoic acid, a helper molecule used by several important enzymes.
The lipoic acid pathway started by the LIPT2 gene helps prepare enzyme systems that break down nutrients for energy. These systems support steady day-to-day cell work, especially in tissues with high energy needs.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These differences are common and help shape normal human diversity, including traits such as appearance, metabolism, and how the body responds to environmental influences. Many variants do not lead to any noticeable effect and are simply part of natural genetic variation. Sometimes, however, a variant changes how a gene works more substantially and can contribute to, or cause, a genetic condition.
Genetic variants
What if the gene does not work
Variants in the LIPT2 gene can change the shape or stability of its enzyme, so cells attach too little of a small helper molecule called lipoic acid to proteins that release energy from food. This is how LIPT2 gene variants affect protein function: some variants partly reduce enzyme activity, while more disruptive variants often leave little or no activity. When the loss is greater, the related condition often starts earlier and can be more severe.
How variants are linked to conditions
Pathogenic variants in both copies of the LIPT2 gene cause a very rare inherited condition called LIPT2 deficiency. Reported cases start in newborns or early infancy and may include low muscle tone, feeding problems, seizures, developmental delay, and high lactic acid levels in the blood. Among LIPT2 gene related conditions, this is the main well-established association in the medical literature.
A variant is not necessarily a diagnosis
Genetic variants are a normal feature of human biology and are common in the general population. Most do not directly affect health and simply reflect natural variation among people. For many genes, having a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors also play a part. In some situations, though, a single well characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the LIPT2 gene. For many living with LIPT2-related changes, risk is mainly shaped by the genetic change itself rather than lifestyle or environmental factors, and a doctor or genetic counselor can help explain personal and family risk.
Inheritance of LIPT2 variants
Variants in the LIPT2 gene linked to LIPT2-related disease are inherited in an autosomal recessive pattern. This means a child usually inherits one nonworking copy from each parent, and the parents are often healthy carriers. When both parents carry a disease-causing variant in the LIPT2 gene, each pregnancy has a 25% chance of being affected, a 50% chance of producing a carrier child, and a 25% chance of producing a child with no familial variant. In practical terms, the LIPT2 inheritance pattern can affect brothers and sisters equally, regardless of sex.
What does my LIPT2 result mean for my family?
For families with a disease-causing change in the LIPT2 gene, the pattern is recessive, so parents are often healthy carriers and brothers or sisters may also be carriers or may be affected. Close relatives may want to learn whether the same gene change runs in the family, especially when there is a history of similar symptoms or early infant illness. Children of an affected person are usually carriers unless the other parent also carries a disease-causing LIPT2 change.
Genetic information
Genetic testing
How you find out about variants
If symptoms suggest a rare energy metabolism condition, genetic testing for LIPT2 variants usually studies DNA from blood or saliva with a test that checks many genes at once or with broader DNA sequencing. The lab reads the LIPT2 gene to look for variants and may confirm important findings with a second method.
When should I consider getting a genetic test?
Testing for the LIPT2 gene may be considered when a baby or child has signs of a rare inherited energy-making condition, such as severe feeding problems, seizures, low muscle tone, developmental problems, or high lactic acid on lab tests. It can also help if there is a family history of a similar condition or both parents are known carriers.
A genetic result is only one part of your health story
Genetic findings can be informative, but how much they explain varies with the condition and the specific type of variant involved. Over time, the way the body works is also shaped by factors like lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic finding may offer a clear answer. In areas such as medication response, genetic results can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Small differences in genes can change how a drug is absorbed, broken down, or used by the body, so the same treatment may work better for some people than for others. These differences are common and can influence both how helpful a medicine is and how sensitive someone may be to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in your genes affect the way you respond to medicines. By studying links between genes and medications, it helps explain why the same treatment can work differently in different people. With many drugs, genes can influence both how powerfully a medicine works and how the body handles it. This information can support treatment choices that are more informed and more tailored to the individual. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the LIPT2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in how medicines work, so concerns about your health, treatment, or possible side effects are best discussed with your doctor or pharmacist.
History
LIPT2 entered the medical literature through research on how cells make use of lipoic acid, a small molecule needed for normal energy production. From these first observations, research expanded steadily, and scientists placed the LIPT2 gene within a pathway that supports key energy making steps inside cells. Its medical importance became clearer when rare inherited variants were identified in people with a mitochondrial condition affecting the body’s ability to use energy. Over time, descriptions became more precise, moving LIPT2 from a basic research finding to a gene with recognized value in rare disease genetics.